A formal test for heterogeneity gave a significant result (Q=720.35 P<0.001, I2=98.3%), the high adiponectin level was associated with decreased breast cancer risk (SMD= -0.873, 95% CI= -1.529--0.217) (Figure 7). Here, ADIPOQ is linked to breast carcinoma.